Multimodal Imaging Global Market Report 2026

Multimodal imaging refers to the sector focused on developing and delivering imaging systems that combine multiple imaging modalities, such as magnetic resonance imaging, computed tomography, positron emission tomography, and ultrasound, to provide comprehensive diagnostic and analytical insights. These systems enhance visualization, enable accurate diagnosis, and improve monitoring by integrating multiple types of imaging data.

The primary products of multimodal imaging include multimodal imaging equipment, reagents, and software. Multimodal imaging equipment refers to advanced systems that combine multiple imaging technologies to deliver comprehensive anatomical and functional insights for precise diagnosis and treatment planning. These solutions utilize technologies such as positron emission tomography combined with computed tomography, single photon emission computed tomography with computed tomography, positron emission tomography with magnetic resonance imaging, and other systems. The applications include oncology, cardiology, neurology, ophthalmology, musculoskeletal conditions, and other clinical areas. The end users include hospitals, diagnostic imaging centers, and other healthcare facilities employing advanced imaging tools for diagnosis and research.

Tariffs on imaging equipment, precision sensors, and radiological components are raising procurement and installation costs in the multimodal imaging market. High value hardware segments such as PET, CT, and MR hybrid systems are most affected due to cross border component sourcing. Hospitals and diagnostic centers in import dependent regions face longer replacement cycles and higher capital budgets. Service and software layers are less exposed but still affected through bundled system pricing. These tariffs are also motivating regional manufacturing partnerships and localized assembly of imaging systems.

The multimodal imaging market research report is one of a series of new reports from The Business Research Company that provides multimodal imaging market statistics, including multimodal imaging industry global market size, regional shares, competitors with a multimodal imaging market share, detailed multimodal imaging market segments, market trends and opportunities, and any further data you may need to thrive in the multimodal imaging industry. This multimodal imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multimodal imaging market size has grown strongly in recent years. It will grow from $4.32 billion in 2025 to $4.61 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growth of advanced diagnostic imaging, rising cancer screening programs, expansion of hospital imaging infrastructure, improvements in detector technology, higher clinical imaging demand.

The multimodal imaging market size is expected to see strong growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increase in precision diagnostics demand, rising chronic disease burden, adoption of AI imaging analytics, growth of hybrid imaging systems, expansion of imaging as a service. Major trends in the forecast period include hybrid pet mr imaging systems, integrated multi modality diagnostics, AI assisted image fusion, cloud based imaging analytics, advanced multimodal visualization software.

The growing need for early and precise disease diagnosis is anticipated to boost the growth of the multimodal imaging market in the future. Early and accurate disease diagnosis involves identifying illnesses at an early stage with high precision using medical data and advanced technologies, enabling timely treatment and improved patient outcomes. The increasing emphasis on early and accurate diagnosis is driven by individuals seeking prompt and precise detection of diseases for better treatment results, allowing healthcare professionals to identify conditions much earlier than in the past. Multimodal imaging supports early and accurate diagnosis by enabling the integration of multiple medical imaging techniques to detect diseases more effectively. For example, in October 2024, according to the National Health Service England, a UK-based public organization, by March 2024 early diagnosis rates were 2.4 percentage points above pre-pandemic levels and 0.8 percentage points higher than the previous year based on Rapid Cancer Registration Data. Therefore, the growing demand for early and accurate disease diagnosis is strengthening the growth of the multimodal imaging market.

Key companies operating in the multimodal imaging market are concentrating on innovations in artificial intelligence and machine learning for image analysis and interpretation, such as AI-assisted image segmentation, which enables automated identification of anatomical structures and regions of interest across various imaging modalities. AI-assisted image segmentation refers to the application of artificial intelligence algorithms to automatically divide images into meaningful regions, a task that traditionally required manual outlining by human specialists. For instance, in September 2025, Revvity, Inc., a US-based company specializing in preclinical imaging solutions, launched Living Image Synergy AI multimodal analysis software. This software provides a unified AI-enabled platform for seamless analysis of in vivo imaging data across optical, microCT, ultrasound, and additional modalities. It reduces data inconsistencies by centralizing workflows and removing reliance on multiple standalone tools. It also integrates advanced AI algorithms to automate image segmentation and region-of-interest quantification, improving accuracy and reproducibility. Intuitive co-registration and automated processes further reduce manual effort and analysis time.

In November 2024, CrestOptics S.p.A., an Italy-based provider of advanced microscopy technologies, partnered with Tomocube Inc. to merge complementary imaging methods into a unified multimodal system. Through this collaboration, both companies planned to co-develop and commercialize the HT X1 Plus imaging platform, which combines holotomography for label-free 3D cellular visualization with spinning-disk confocal fluorescence microscopy. This partnership aims to allow researchers to collect both structural and molecular data from the same samples, improving workflows in live-cell imaging, tissue analysis, and developmental biology. Tomocube Inc. is a South Korea-based company specializing in holotomography imaging solutions for quantitative 3D cellular and tissue analysis.

Major companies operating in the multimodal imaging market are Samsung Medison Co. Ltd., Analogic Corporation, Alcon Inc., Hologic Inc., Sofie Biosciences Inc., ShanghAI United Imaging Healthcare Co. Ltd., Topcon Corporation, Agfa-Gevaert Group, Heidelberg Engineering GmbH, Optos plc, RefleXion Medical Inc., Neusoft Corporation, Infraredx Inc., MinFound Medical Systems Co. Ltd., Neusoft Medical Systems Co. Ltd., Spectrum Dynamics Medical LLC, Konica Minolta Healthcare Americas Inc., Esaote S.p.A., MR Solutions Ltd., MILabs B.V., NIDEK Co. Ltd., Kowa Company Ltd., and Positron Corporation.

North America was the largest region in the multimodal imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multimodal imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multimodal imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multimodal imaging market consists of revenues earned by entities by providing services such as installation and commissioning, system integration, maintenance and repair, calibration and quality assurance, software support and updates, imaging data analysis, cloud data management, training and education, imaging as a service and consulting and workflow optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The multimodal imaging market includes sales of magnetic resonance imaging (MRI) scanners, computed tomography (CT) scanners, ultrasound systems, optical imaging systems, multimodal imaging systems, imaging detectors and radiofrequency coils, imaging workstations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multimodal Imaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses multimodal imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multimodal imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multimodal imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Multimodal Imaging Equipment; Reagents; Software
• 2) By Technology: Positron Emission Tomography (PET) Or Computed Tomography (CT) Systems; Single Photon Emission Computed Tomography Or Computed Tomography (CT) Systems; Positron Emission Tomography (PET) Or Magnetic Resonance (MR) Systems; Other Technologies
• 3) By Application: Oncology; Cardiology; Neurology; Ophthalmology; Musculoskeletal Disorders; Other Applications
• 4) By End-User: Hospitals; Diagnostic Imaging Centers; Other End-Users
• Subsegments:
• 1) By Multimodal Imaging Equipment: Magnetic Resonance Imaging Scanner; Computed Tomography Scanner; Positron Emission Tomography Scanner; Single Photon Emission Computed Tomography Scanner; Optical Imaging System; Photoacoustic Imaging System; Hybrid Imaging System
• 2) By Reagents: Contrast Agents; Radiopharmaceuticals; Fluorescent Dyes; Molecular Probes
• 3) By Software: Image Processing Software; Analysis And Visualization Software; Data Management Software; Workflow And Reporting Software
• Companies Mentioned: Samsung Medison Co. Ltd.; Analogic Corporation; Alcon Inc.; Hologic Inc.; Sofie Biosciences Inc.; ShanghAI United Imaging Healthcare Co. Ltd.; Topcon Corporation; Agfa-Gevaert Group; Heidelberg Engineering GmbH; Optos plc; RefleXion Medical Inc.; Neusoft Corporation; Infraredx Inc.; MinFound Medical Systems Co. Ltd.; Neusoft Medical Systems Co. Ltd.; Spectrum Dynamics Medical LLC; Konica Minolta Healthcare Americas Inc.; Esaote S.p.A.; MR Solutions Ltd.; MILabs B.V.; NIDEK Co. Ltd.; Kowa Company Ltd.; and Positron Corporation.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.